Assignment of Assignor's Interest

Recorded: 2019-03-15 Pages: 3

Assignors

GOLDSTEIN, DAVID MICHAEL

Executed: 2013-06-12

BRAMELD, KENNETH ALBERT

Executed: 2013-06-12

Assignee

PRINCIPIA BIOPHARMA INC.

400 EAST JAMIE COURT, SUITE 302, SOUTH SAN FRANCISCO, CALIFORNIA, 94080

Covered Properties (6)

Tyrosine Kinase Inhibitors

Patent: 8,673,925 →

Application: 13/929,004 →

Tyrosine Kinase Inhibitors

Patent: 8,759,358 →

Application: 13/929,179 →

Tyrosine Kinase Inhibitors

Patent: 8,946,241 →

Application: 14/185,687 →

Publication: US 2014/0303190

Tyrosine Kinase Inhibitors

Patent: 9,090,621 →

Application: 14/255,842 →

Publication: US 2014/0309223

Tyrosine Kinase Inhibitors

Patent: 8,962,635 →

Application: 14/341,421 →

Publication: US 2014/0336382

Tyrosine Kinase Inhibitors

Application: 14/741,311 →

Publication: US 2015/0353562

Related Assignments (2)

Other recorded transfers of the patents in this record — the chain of ownership.